TY - JOUR AU - Harrington, K. PY - 2019 DA - 2019// TI - Optimizing oncolytic virotherapy in cancer treatment JO - Nat Rev Drug Discov VL - 18 UR - https://doi.org/10.1038/s41573-019-0029-0 DO - 10.1038/s41573-019-0029-0 ID - Harrington2019 ER - TY - JOUR AU - Russell, S. J. AU - Peng, K. W. AU - Bell, J. C. PY - 2012 DA - 2012// TI - Oncolytic virotherapy JO - Nat Biotechnol VL - 30 UR - https://doi.org/10.1038/nbt.2287 DO - 10.1038/nbt.2287 ID - Russell2012 ER - TY - JOUR AU - Bommareddy, P. K. AU - Shettigar, M. AU - Kaufman, H. L. PY - 2018 DA - 2018// TI - Integrating oncolytic viruses in combination cancer immunotherapy JO - Nat Rev Immunol VL - 18 UR - https://doi.org/10.1038/s41577-018-0014-6 DO - 10.1038/s41577-018-0014-6 ID - Bommareddy2018 ER - TY - JOUR AU - Andtbacka, R. H. PY - 2015 DA - 2015// TI - Talimogene laherparepvec improves durable response rate in patients with advanced melanoma JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.3377 DO - 10.1200/JCO.2014.58.3377 ID - Andtbacka2015 ER - TY - JOUR AU - Twumasi-Boateng, K. PY - 2018 DA - 2018// TI - Oncolytic viruses as engineering platforms for combination immunotherapy JO - Nat Rev Cancer VL - 18 UR - https://doi.org/10.1038/s41568-018-0009-4 DO - 10.1038/s41568-018-0009-4 ID - Twumasi-Boateng2018 ER - TY - JOUR AU - Li, X. D. PY - 1992 DA - 1992// TI - Isolation of Getah virus from mosquitos collected on Hainan Island, China, and results of a serosurvey JO - Southeast Asian J Trop Med Public Health VL - 23 ID - Li1992 ER - TY - JOUR AU - Lin, Y. PY - 2014 DA - 2014// TI - Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers JO - Proc Natl Acad Sci USA VL - 111 UR - https://doi.org/10.1073/pnas.1408759111 DO - 10.1073/pnas.1408759111 ID - Lin2014 ER - TY - JOUR AU - Zhang, H. PY - 2016 DA - 2016// TI - Naturally existing oncolytic virus M1 is nonpathogenic for the nonhuman primates after multiple rounds of repeated intravenous injections JO - Hum Gene Ther VL - 27 UR - https://doi.org/10.1089/hum.2016.038 DO - 10.1089/hum.2016.038 ID - Zhang2016 ER - TY - JOUR AU - Zhang, H. PY - 2017 DA - 2017// TI - Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma JO - Sci Transl Med VL - 9 UR - https://doi.org/10.1126/scitranslmed.aam7996 DO - 10.1126/scitranslmed.aam7996 ID - Zhang2017 ER - TY - JOUR AU - Xiao, X. PY - 2018 DA - 2018// TI - DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage JO - Nat Commun VL - 9 UR - https://doi.org/10.1038/s41467-018-06771-4 DO - 10.1038/s41467-018-06771-4 ID - Xiao2018 ER - TY - JOUR AU - Tan, Y. PY - 2017 DA - 2017// TI - Selective antagonism of Bcl-xL potentiates M1 oncolysis by enhancing mitochondrial apoptosis JO - Hum Gene Ther UR - https://doi.org/10.1089/hum.2017.055 DO - 10.1089/hum.2017.055 ID - Tan2017 ER - TY - JOUR AU - Goodwin, C. M. AU - Xu, S. AU - Munger, J. PY - 2015 DA - 2015// TI - Stealing the keys to the kitchen: viral manipulation of the host cell metabolic network JO - Trends Microbiol VL - 23 UR - https://doi.org/10.1016/j.tim.2015.08.007 DO - 10.1016/j.tim.2015.08.007 ID - Goodwin2015 ER - TY - JOUR AU - Warburg, O. PY - 1956 DA - 1956// TI - On respiratory impairment in cancer cells JO - Science VL - 124 ID - Warburg1956 ER - TY - JOUR AU - Thai, M. PY - 2014 DA - 2014// TI - Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication JO - Cell Metab VL - 19 UR - https://doi.org/10.1016/j.cmet.2014.03.009 DO - 10.1016/j.cmet.2014.03.009 ID - Thai2014 ER - TY - JOUR AU - Xiao, L. PY - 2014 DA - 2014// TI - Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy JO - Oncogene VL - 33 UR - https://doi.org/10.1038/onc.2014.32 DO - 10.1038/onc.2014.32 ID - Xiao2014 ER - TY - JOUR AU - Ramiere, C. PY - 2014 DA - 2014// TI - Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A JO - J Virol VL - 88 UR - https://doi.org/10.1128/JVI.02862-13 DO - 10.1128/JVI.02862-13 ID - Ramiere2014 ER - TY - JOUR AU - Fontaine, K. A. PY - 2015 DA - 2015// TI - Dengue virus induces and requires glycolysis for optimal replication JO - J Virol VL - 89 UR - https://doi.org/10.1128/JVI.02309-14 DO - 10.1128/JVI.02309-14 ID - Fontaine2015 ER - TY - JOUR AU - Floridi, A. PY - 1981 DA - 1981// TI - Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells JO - J Natl Cancer Inst VL - 66 ID - Floridi1981 ER - TY - JOUR AU - Sadler, A. J. AU - Williams, B. R. PY - 2008 DA - 2008// TI - Interferon-inducible antiviral effectors JO - Nat Rev Immunol VL - 8 UR - https://doi.org/10.1038/nri2314 DO - 10.1038/nri2314 ID - Sadler2008 ER - TY - JOUR AU - Walter, P. AU - Ron, D. PY - 2011 DA - 2011// TI - The unfolded protein response: from stress pathway to homeostatic regulation JO - Science VL - 334 UR - https://doi.org/10.1126/science.1209038 DO - 10.1126/science.1209038 ID - Walter2011 ER - TY - JOUR AU - Koppenol, W. H. AU - Bounds, P. L. AU - Dang, C. V. PY - 2011 DA - 2011// TI - Otto Warburg's contributions to current concepts of cancer metabolism JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3038 DO - 10.1038/nrc3038 ID - Koppenol2011 ER - TY - JOUR AU - Bhutia, Y. D. AU - Babu, E. AU - Ganapathy, V. PY - 2016 DA - 2016// TI - Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine JO - Biochemical Journal VL - 473 UR - https://doi.org/10.1042/BCJ20160068 DO - 10.1042/BCJ20160068 ID - Bhutia2016 ER - TY - JOUR AU - Jiang, H. PY - 2016 DA - 2016// TI - PFKFB3-Driven Macrophage Glycolytic Metabolism Is a Crucial Component of Innate Antiviral Defense JO - J Immunol VL - 197 UR - https://doi.org/10.4049/jimmunol.1600474 DO - 10.4049/jimmunol.1600474 ID - Jiang2016 ER - TY - JOUR AU - Pikor, L. A. AU - Bell, J. C. AU - Diallo, J. S. PY - 2015 DA - 2015// TI - Oncolytic Viruses: Exploiting Cancer's Deal with the Devil JO - Trends Cancer VL - 1 UR - https://doi.org/10.1016/j.trecan.2015.10.004 DO - 10.1016/j.trecan.2015.10.004 ID - Pikor2015 ER - TY - JOUR AU - Kaufman, H. L. AU - Kohlhapp, F. J. AU - Zloza, A. PY - 2015 DA - 2015// TI - Oncolytic viruses: a new class of immunotherapy drugs JO - Nat Rev Drug Discov VL - 14 UR - https://doi.org/10.1038/nrd4663 DO - 10.1038/nrd4663 ID - Kaufman2015 ER - TY - JOUR AU - Mansour, M. AU - Palese, P. AU - Zamarin, D. PY - 2011 DA - 2011// TI - Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells JO - J Virol VL - 85 UR - https://doi.org/10.1128/JVI.01537-10 DO - 10.1128/JVI.01537-10 ID - Mansour2011 ER - TY - JOUR AU - Strong, J. E. PY - 1998 DA - 1998// TI - The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus JO - EMBO J VL - 17 UR - https://doi.org/10.1093/emboj/17.12.3351 DO - 10.1093/emboj/17.12.3351 ID - Strong1998 ER - TY - JOUR AU - Parato, K. A. PY - 2012 DA - 2012// TI - The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers JO - Mol Ther VL - 20 UR - https://doi.org/10.1038/mt.2011.276 DO - 10.1038/mt.2011.276 ID - Parato2012 ER - TY - JOUR AU - Farassati, F. AU - Yang, A. D. AU - Lee, P. W. PY - 2001 DA - 2001// TI - Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1 JO - Nat Cell Biol VL - 3 UR - https://doi.org/10.1038/35087061 DO - 10.1038/35087061 ID - Farassati2001 ER - TY - JOUR AU - Cuddington, B. P. AU - Mossman, K. L. PY - 2014 DA - 2014// TI - Permissiveness of human cancer cells to oncolytic bovine herpesvirus 1 is mediated in part by KRAS activity JO - J Virol VL - 88 UR - https://doi.org/10.1128/JVI.00849-14 DO - 10.1128/JVI.00849-14 ID - Cuddington2014 ER -